临床试验:食品供应中的乳化剂对克罗恩病疾病活动度的影响:一项探索性双盲随机喂养试验
这项双盲随机喂养试验将24例有症状、超声活动性回肠受累的克罗恩病患者随机分配至乳化剂高含量饮食(HED)或低含量饮食(LED)组,为期4周。结果显示两组临床缓解率、超声指标、生活质量和疲劳均有改善,但饮食间无统计学显著差异。在健康饮食背景下,4周内乳化剂含量对疾病活动度无影响,不支持活动期克罗恩病患者避免乳化剂的建议。
要点
- HED组9/12和LED组7/12达到临床缓解(HBI<5),两组间无统计学显著差异。
- IBUS-SAS在HED组从51降至33(p=0.014),在LED组从57降至44(p=0.01)。
- 完成研究者中,肠壁厚度在HED组降低34%,在LED组降低15%。
核心结论
- 在健康饮食背景下,4周内乳化剂含量对克罗恩病患者的疾病活动度无影响。
- 不支持活动期克罗恩病患者避免乳化剂的建议。
研究设计与样本
- 双盲、随机喂养研究,纳入24例有症状、超声活动性回肠受累且稳定药物治疗≥2个月的成人克罗恩病患者。
- 随机分配至4周乳化剂高含量饮食(HED)或低含量饮食(LED)组,饮食模式基于澳大利亚健康饮食指南。
主要发现
- 共随机24例患者,平均年龄37岁(95%CI 32, 41),男性12例,HBI 6(6, 8),肠壁厚度6.0(5.5-6.6)mm。
- 依从性>95%;临床缓解(HBI<5)在HED组为9/12,在LED组为7/12;分别有2例和3例因胃肠道症状加重提前退出。
- IBUS-SAS在HED组从51(35, 68)降至33(15, 51)(p=0.014),在LED组从57(38, 76)降至44(29, 59)(p=0.01)。
- 完成研究者中,肠壁厚度在HED组降低34%,在LED组降低15%。
- 生活质量和疲劳在两种饮食下均有改善(p≤0.05);饮食间结局无统计学显著差异。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Advice to avoid dietary emulsifiers in Crohn's disease (CD) is based on preclinical data. AIMS: To examine the effect of diets high (HED) and low (LED) in emulsifiers in the food supply on disease activity in CD. METHODS: In a double-blinded, randomised feeding study, we randomised adults with symptomatic, sonographically active CD with ileal involvement on ≥ 2 months' stable medical therapy to 4 weeks of a HED or LED modelled on Australian healthy eating guidelines. We measured the Harvey-Bradshaw Index (HBI), sonographic indices (IBUS-SAS, bowel wall thickness), quality of life (QOL) and fatigue at baseline and study completion. RESULTS: We randomised 24 patients, mean age 37 (95% CI 32, 41) years, 12 male, HBI 6 (6, 8), bowel wall thickness 6.0 (5.5-6.6) mm. Adherence was > 95%. Clinical remission (HBI < 5) occurred in 9/12 on HED and 7/12 on LED; 2 and 3, respectively, withdrew early with increasing gastrointestinal symptoms. IBUS-SAS fell from 51 (35, 68) to 33 (15, 51) on HED (p = 0.014) and from 57 (38, 76) to 44 (29, 59) on LED (p = 0.01). Bowel wall thickness reduced by 34% on HED and 15% on LED in those who completed the study. QOL and fatigue improved on both diets (p ≤ 0.05). There were no statistically significant differences in outcomes between diets. CONCLUSIONS: In the context of a healthy diet, the emulsifier content had no influence over disease activity over 4 weeks in patients with CD. Recommendations to avoid emulsifiers in patients with active CD are not supported. Australian New Zealand Clinical Trials Registry (ACTRN12619001099112).
引用
- Fitzpatrick JA, Gibson PR, Taylor KM, et al. Clinical Trial: The Effects of Emulsifiers in the Food Supply on Disease Activity in Crohn's Disease: An Exploratory Double-Blinded Randomised Feeding Trial. Aliment Pharmacol Ther. 2025. PMID: 39967287. doi:10.1111/apt.70041
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。